See more : Nxt-ID, Inc. (NXTD) Income Statement Analysis – Financial Results
Complete financial analysis of Emerging World Pharma, Inc. (EWPI) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Emerging World Pharma, Inc., a leading company in the Financial – Conglomerates industry within the Financial Services sector.
- Alveen S.A. (MLALV.PA) Income Statement Analysis – Financial Results
- Niko Semiconductor Co., Ltd. (3317.TWO) Income Statement Analysis – Financial Results
- Archidply Decor Limited (ADL.NS) Income Statement Analysis – Financial Results
- Mirai Industry Co.,Ltd. (7931.T) Income Statement Analysis – Financial Results
- THOR Financial Technologies Tru (THIR) Income Statement Analysis – Financial Results
Emerging World Pharma, Inc. (EWPI)
Industry: Financial - Conglomerates
Sector: Financial Services
About Emerging World Pharma, Inc.
Emerging World Pharma, Inc. invests in generic based pharmaceutical companies manufacturing within developing nations. It provides production infrastructure, hiring and training of local employees, and raw materials to these companies. The company focuses its investments on pharmaceutical companies that have contracts with church and other non government organizations, government, and wholesalers. Emerging World Pharma, Inc. was formerly known as Tubearoo, Inc. and changed its name to Emerging World Pharma, Inc. in November 2009. The company was founded in 1997 and is based in Sunyani, Ghana.
Source: https://incomestatements.info
Category: Stock Reports